In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR β-CDR3 sequencing
- 1 July 2004
- journal article
- Published by Elsevier in The Lancet
- Vol. 364 (9431), 355-364
- https://doi.org/10.1016/s0140-6736(04)16724-x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Autoantibodies frequently detected in patients with aplastic anemiaBlood, 2003
- Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppressionBlood, 2002
- A functional and structural basis for TCR cross-reactivity in multiple sclerosisNature Immunology, 2002
- Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by Vβ CDR3 spectratyping and flow cytometryBlood, 2002
- Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemiaSeminars in Hematology, 2000
- T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.The Journal of Experimental Medicine, 1995
- Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemiaBritish Journal of Haematology, 1995
- Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic proteinCell, 1995
- T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor β-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseasesResearch in Immunology, 1995
- Circulating Activated Suppressor T Lymphocytes in Aplastic AnemiaNew England Journal of Medicine, 1985